Paper20037584
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.
Stewart CR and 13 others. Nat Immunol, 2010. Cited by 1,262 papers, by iCite.
Cite this record
ConductScience Library. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Papers, record 20037584. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20037584
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD36 Antigens | Major topic |
| Inflammation | Major topic |
| Signal Transduction | Major topic |
| Toll-Like Receptor 4 | Major topic |
| Toll-Like Receptor 6 | Major topic |
| Amyloid beta-Peptides | |
| Animals | |
| Atherosclerosis | |
| Blotting, Western | |
| Cell Line | |
| Chemokines | |
| Gene Expression | |
| Humans | |
| Immunoprecipitation | |
| Lipoproteins, LDL | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Microglia | |
| Reverse Transcriptase Polymerase Chain Reaction |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 NS059005 | NINDS NIH HHS | United States | R01NS059005 | PubMed and NIH | NIH RePORTER |
| P30 DK043351 | NIDDK NIH HHS | United States | P30DK043351 | PubMed and NIH | NIH RePORTER |
| 068089 | Wellcome Trust | United Kingdom | PubMed | PubMed | |
| R01 AG032349 | NIA NIH HHS | United States | R01AG032349 | PubMed and NIH | NIH RePORTER |
| R01 AG020255 | NIA NIH HHS | United States | R01AG020255 | PubMed and NIH | NIH RePORTER |
| R01 AI079198 | NIAID NIH HHS | United States | R01AI079198 | PubMed and NIH | NIH RePORTER |
| R01AG20255 | NIA NIH HHS | United States | R01AG020255 | PubMed and NIH | NIH RePORTER |
| R01NS059005 | NINDS NIH HHS | United States | R01NS059005 | PubMed and NIH | NIH RePORTER |
| 068089/Z/02/Z | Wellcome Trust | United Kingdom | PubMed | PubMed |
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16061696 | Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. | J Cell Biol | 2005 | https://conductscience.org/library/papers/16061696 | PubMed |
| 2 | 16960575 | Inflammation in Alzheimer disease: driving force, bystander or beneficial response? | Nat Med | 2006 | https://conductscience.org/library/papers/16960575 | PubMed |
| 3 | 9006967 | Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. | J Neurosci | 1997 | https://conductscience.org/library/papers/9006967 | PubMed |
| 4 | 11593030 | Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11593030 | PubMed |
| 5 | 16075060 | Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. | J Clin Invest | 2005 | https://conductscience.org/library/papers/16075060 | PubMed |
| 6 | 15690042 | CD36 is a sensor of diacylglycerides. | Nature | 2005 | https://conductscience.org/library/papers/15690042 | PubMed |
| 7 | 18297073 | TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. | Nat Immunol | 2008 | https://conductscience.org/library/papers/18297073 | PubMed |
| 8 | 18180310 | Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome. | J Exp Med | 2008 | https://conductscience.org/library/papers/18180310 | PubMed |
| 9 | 15034566 | Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. | Nat Med | 2004 | https://conductscience.org/library/papers/15034566 | PubMed |
| 10 | 16157451 | Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. | Neurosci Lett | 2006 | https://conductscience.org/library/papers/16157451 | PubMed |
| 11 | 18250194 | Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. | J Exp Med | 2008 | https://conductscience.org/library/papers/18250194 | PubMed |
| 12 | 17977705 | The inflammasome: a danger sensing complex triggering innate immunity. | Curr Opin Immunol | 2007 | https://conductscience.org/library/papers/17977705 | PubMed |
| 13 | 12719479 | Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. | J Exp Med | 2003 | https://conductscience.org/library/papers/12719479 | PubMed |
| 14 | 17392283 | Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17392283 | PubMed |
| 15 | 18510752 | Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. | J Neuroinflammation | 2008 | https://conductscience.org/library/papers/18510752 | PubMed |
| 16 | 2460250 | Immortalization of cloned mouse splenic macrophages with a retrovirus containing the v-raf/mil and v-myc oncogenes. | Cell Immunol | 1988 | https://conductscience.org/library/papers/2460250 | PubMed |
| 17 | 10938017 | Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. | Arterioscler Thromb Vasc Biol | 2000 | https://conductscience.org/library/papers/10938017 | PubMed |
| 18 | 18516040 | A Toll-like receptor 2-integrin beta3 complex senses bacterial lipopeptides via vitronectin. | Nat Immunol | 2008 | https://conductscience.org/library/papers/18516040 | PubMed |
| 19 | 12615675 | Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. | Arterioscler Thromb Vasc Biol | 2003 | https://conductscience.org/library/papers/12615675 | PubMed |
| 20 | 16728653 | Scavenger receptors in atherosclerosis: beyond lipid uptake. | Arterioscler Thromb Vasc Biol | 2006 | https://conductscience.org/library/papers/16728653 | PubMed |
Cited by837
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,262 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983584 | Brain clearance of protein aggregates in degenerative diseases: the role of microglia and astrocytes. | Transl Neurodegener | 2026 | https://conductscience.org/library/papers/42983584 | PubMed |
| 42946800 | Macrophage biology and immunoregulation in health and disease. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/42946800 | PubMed |
| 42792179 | From Retina to Vasculature: Oxidative Stress as a Common Mechanistic Link Between Age-Related Macular Degeneration and Cardiovascular Disease. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42792179 | PubMed |
| 42746188 | CD36 in asthma: from a candidate immunometabolic checkpoint to genetic susceptibility. | Front Immunol | 2026 | https://conductscience.org/library/papers/42746188 | PubMed |
| 42741604 | Source-renewing ectopic ApoB-TRL lipolysis in non-resolving ARDS: a testable spatial hypothesis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42741604 | PubMed |
| 42696452 | The regulation of COX-2, ABCA1, and ABCG1 by the lncRNA PACERR links the inflammatory response and cholesterol homeostasis. | Cell Rep | 2026 | https://conductscience.org/library/papers/42696452 | PubMed |
| 42694900 | Targeting Inflammation in Atherosclerosis: Mechanistic Rationale, Clinical Trials, and Regulatory Considerations. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42694900 | PubMed |
| 42642835 | Unraveling Neurodegeneration: Common Molecular Mechanisms and Novel Therapeutic Concepts in Major Neurodegenerative Disorders. | Brain Behav | 2026 | https://conductscience.org/library/papers/42642835 | PubMed |
| 42563993 | Metabolic reprogramming orchestrates microglial fate in cerebral ischemia-reperfusion injury: a spatiotemporal immunometabolic perspective. | Front Immunol | 2026 | https://conductscience.org/library/papers/42563993 | PubMed |
| 42558044 | Macrophage PIM1 Drives Atherosclerosis by Enhancing Foam Cell Formation Via CD36. | Arterioscler Thromb Vasc Biol | 2026 | https://conductscience.org/library/papers/42558044 | PubMed |
| 42550363 | A Review on Structural Insights into NLRP3 and NEK7: Domain Architecture, Subcellular Localization, and Their Interaction in Inflammasome Assembly and Signaling. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42550363 | PubMed |
| 42528040 | Targeting Inflammation in Atherosclerotic Cardiovascular Disease: Mechanisms and Emerging Therapies. | Immunol Rev | 2026 | https://conductscience.org/library/papers/42528040 | PubMed |
| 42516401 | Pathogen effects on the brain: the case of SARS-CoV-2 spike protein and neuro COVID. | Front Neurol | 2026 | https://conductscience.org/library/papers/42516401 | PubMed |
| 42463535 | CD36: bridging metabolism, inflammation, and reproduction. | NPJ Metab Health Dis | 2026 | https://conductscience.org/library/papers/42463535 | PubMed |
| 42443330 | Macrophage CCRL2 promotes NLRP3 inflammasome activation to exacerbate atherosclerosis. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/42443330 | PubMed |
| 42438074 | Combating ageing beyond the cell: Emerging roles of extracellular proteostasis. | FEBS J | 2026 | https://conductscience.org/library/papers/42438074 | PubMed |
| 42417935 | Regulation of NLRP3 inflammasome signaling in Alzheimer's disease: emerging neuroprotective role of phytochemicals. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42417935 | PubMed |
| 42393750 | Microglial checkpoint collapse in Alzheimer's disease: a tri-axial framework for biomarker-informed neuroimmune therapy. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/42393750 | PubMed |
| 42313211 | Targeting NLRP3 inflammasome to mitigate chemotherapy-induced cardiotoxicity: advances in selective inhibitors and natural modulators. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42313211 | PubMed |
| 42192778 | The Effect of Metabolic Syndrome on Alzheimer's Disease: Physical Activity as a Preventive and Therapeutic Measure. | Brain Sci | 2026 | https://conductscience.org/library/papers/42192778 | PubMed |
Genes33
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20037584
GET https://conductscience.org/api/papers/v1/20037584/references?page=2